Login / Signup
Weekly Journal Scan: SELECT renoprotective effects of semaglutide in non-diabetic, obese patients with cardiovascular disease.
Rocco Vergallo
Massimo Volpe
Published in:
European heart journal (2024)
Keyphrases
</>
cardiovascular disease
type diabetes
computed tomography
adipose tissue
weight loss
metabolic syndrome
wound healing
obese patients
cardiovascular events
diabetic nephropathy
cardiovascular risk factors
bariatric surgery